News
11-08-2010, 01:51 AM
Amgen is pleased to announce that it has won the Best New Drug award for Prolia™ (denosumab), a novel treatment approved in the United States (U.S.) for women with postmenopausal osteoporosis at high risk for fracture, at the 2010 Scrip Awards ceremony Nov. 4 in London. Named one of TIME's Top 10 Medical Breakthroughs of 2009, Prolia is the first treatment specifically designed to target osteoclasts, the cells that break down bone.
More... (http://www.news-medical.net/news/20101108/Amgen-wins-Scrip-Best-New-Drug-award-for-Prolia.aspx)
More... (http://www.news-medical.net/news/20101108/Amgen-wins-Scrip-Best-New-Drug-award-for-Prolia.aspx)